X @Bloomberg
Bloomberg·2025-12-11 06:36
Market Performance - Novo Nordisk shares have significantly decreased this year, reversing the previous surge driven by weight-loss drugs [1] Industry Trend - The report suggests a potential cooling of the market enthusiasm surrounding weight-loss drugs, which previously fueled Novo Nordisk's rapid growth [1]